These data demonstrated that CEA−/lo CRC cells were quiescent and resistant to chemotherapeutic agents, and could give rise to CEA+ cells, indicating that the CEA−/lo factions are slow cycling and can differentiate into CEA+ cells. This evidence concerns the gene CEACAM5 and colorectal carcinoma.